Ipca Laboratories Ltd (BOM:524494)
₹ 1557.15 25.65 (1.67%) Market Cap: 395.06 Bil Enterprise Value: 400.99 Bil PE Ratio: 68.50 PB Ratio: 6.24 GF Score: 91/100

Q3 2022 IPCA Laboratories Ltd Earnings Call Transcript

Feb 15, 2022 / 11:00AM GMT
Release Date Price: ₹989.2 (+2.54%)
Operator

Ladies and gentlemen, good day, and welcome to the Ipca Laboratories Q3 FY'22 Earnings Conference Call hosted by DAM Capital Advisors Limited. (Operator Instructions) Please note that this conference is being recorded. I now hand the conference over to Mr. Nitin Agarwal from DAM Capital Advisors Limited. Thank you, and over to you, sir.

Nitin Agarwal
DAM Capital Advisors Limited, Research Division - Head of Research

Thank you, [Vivian], and good afternoon, everyone, and a very warm welcome to Ipca Labs Q3 FY'22 post earnings call hosted by DAM Capital Advisors Limited. On the call today, we have representing Ipca Lab management, Mr. A.K. Jain, Joint Managing Director; and Mr. Harish Kamath, Corporate Counsel and Company secretary. I will hand over the call to Mr. Jain for opening comments, and then we'll open the floor for questions and answers. Mr. Jain, please go ahead.

Ajit Kumar Bhanwarlal Jain
Ipca Laboratories Limited - CFO, Joint MD & Executive Director

Thanks, Nitin, and DAM Capital for organizing this

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot